Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Westhouse Medical Services Acquires Majority Stake in Quy Biosciences - Medical Product Outsourcing

Westhouse Medical Services Acquires Majority Stake in Quy Biosciences

A full acquisition is planned.

Westhouse Medical Services plc, a London, United Kingdom-based medical device maker, has acquired a 52 percent stake in Quy Biosciences Ltd. The per share price gives the Oxfordshire-based company a $5.2 million value, though precise terms of the deal were not disclosed.

Westhouse plans to purchase the remaining 48 percent of Quy Biosciences shares in the “near future.” Company executives were not more specific on a timeline for the purchase.

Quy develops develop clinical products and services in the regenerative medicine field. The company currently is researching wound healing technology in an effort to develop stem cell therapy products.

“This acquisition will further enhance Westhouse’s IP [intellectual property] portfolio and make a significant contribution to the company’s world wide development whilst meeting the company’s ethos of bringing technology to market for the benefit of patients globally,” said Jack Kaye, chairman of Westhouse.

Currently, Westhouse also is developing various new medical devices, including BreastCheck—a low-cost, non-invasive breast cancer-screening product intended to act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired a procedure called Pneumatic Trabeculoplasty (PNT) from Fountain Hills, Ariz.-based Sunridge International via Sunridge’s subsidiary, Ophthalmic International Inc. The procedure treats glaucoma and ocular hypertension, and is CE marked for use in Europe.




Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters